Moreover, the high proliferation index of our BCL6 DHL cases is associated with low/equivocal CD10 expression and co-immunopositivity of MUM1, MYC, BCL2 and BCL6 protein expression, and these patients were more likely to be non-GCB type DLBCL. The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.